Israel - English - Ministry of Health

promedico ltd - iodine as ethyl esters of iodized fatty acids of poppy seed oil - solution for injection - iodine as ethyl esters of iodized fatty acids of poppy seed oil 480 mg/ml - non watersoluble x-ray contrast media - lymphography.- visualisation, localisation and vectorisation during trans-arterial chemo-embolisation (tace) of hepatocellular carcinoma, in adults.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

friskies pet care pty ltd - esters of essential fatty acids cosmetics | diazinon - parasiticides - cat | cat - queen | cat - tom | kitten - flea | ctenocephalides spp. | ground fleas

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

friskies pet care pty ltd - esters of essential fatty acids cosmetics | diazinon - parasiticides - dog | bitch | castrate | puppy - flea | ctenocephalides spp. | ground fleas

Singapore - English - HSA (Health Sciences Authority)

transmedic pte ltd - ethyl esters of iodised fatty acids of poppy-seed oil - injection - 38% w/w - ethyl esters of iodised fatty acids of poppy-seed oil 38% w/w

Ireland - English - HPRA (Health Products Regulatory Authority)

epax as - omega-3-acid ethyl esters 90 - capsules, soft - 1000 milligram

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd agribusiness pty ltd - diazinon; hydrocarbon solvent - topical solution/suspension - diazinon organophosphorus active 200.0 g/l; hydrocarbon solvent solvent other 636.0 g/l - parasiticides - cattle | goat | pigs | sheep | beef | billy | boar | bos indicus | bos taurus | bovine | buck | buffalo | bull | bullock | calf - australian sheep blowfly | cattle biting louse | common goat louse | longnosed cattle louse | pig louse | sarcoptic mange scabies mite | sheep body louse | sheep ked | shortnosed cattle louse | blowfly organophosphate resist | cattlebiting louse | damalinia bovis (old name) | damalinia ovis (prev. genus) | lice - synthetic pyrethroid re | long-nosed sucking louse | sheep body lice | short nosed sucking louse

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - omega-3-acid ethyl esters 90, quantity: 1000 mg - capsule, soft - excipient ingredients: purified water; gelatin; glycerol; d-alpha-tocopherol - hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response. treatment is indicated for the following types of dyslipidaemia (fredrickson classification) only: -type iv & v as monotherapy and with close monitoring of ldl-c levels. - type iib as add-on therapy to statins, when control of triglycerides with statins has been shown to be insufficient. patients with higher baseline levels of triglycerides are more likely to exhibit a better response to omacor. omacor is not indicated in exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). there are insufficient data to support the use in patients with secondary endogenous hypertriglyceridaemia including patients with diabetes mellitus.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - methyl esters of canola oil fatty acids - emulsifiable concentrate - methyl esters of canola oil fatty acids ester active 725.0 g/l - adjuvant - cotton defoliation | defoliant additive | desiccant additive | fungicide additive | herbicide additive | insecticide additive | - defoliation of cotton plants | tank mixing | wetting agent (use as directed) | additive | agricultural chemical | defoliation aid | herbicide | improve penetrating properties | minimise antagonism | spray tank

United States - English - NLM (National Library of Medicine)

par pharmaceutical inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - omega-3-acid ethyl esters capsules, usp are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules, usp and should continue this diet during treatment with omega-3-acid ethyl esters capsules, usp. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting  therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug ther

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - -  omega-3-acid ethyl esters is indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). -   usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters and should continue this diet during treatment with omega-3-acid ethyl esters. -  laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. -